Gilead signals major hep C trouble ahead with sales guidance tweak
admin 27th October 2017 Uncategorised 0Gilead’s doing its best to move away from hepatitis C. But as usual, it was that topic that dominated the discussion on Thursday’s third-quarter earnings call—and it wasn’t a positive discussion.
More: Gilead signals major hep C trouble ahead with sales guidance tweak
Source: fierce